Ligand Pharmaceuticals General Stock Performance
| LGNYZ Stock | USD 0.01 0.00 0.00% |
Ligand Pharmaceuticals holds a performance score of 21 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -27.78, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Ligand Pharmaceuticals are expected to decrease by larger amounts. On the other hand, during market turmoil, Ligand Pharmaceuticals is expected to outperform it. Use Ligand Pharmaceuticals value at risk, kurtosis, and the relationship between the sortino ratio and semi variance , to analyze future returns on Ligand Pharmaceuticals.
Risk-Adjusted Performance
21 of 100
Weak | Strong |
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Ligand Pharmaceuticals General are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Ligand Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 48 M | |
| Free Cash Flow | 70 M |
Ligand |
Ligand Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 0.31 in Ligand Pharmaceuticals General on January 24, 2024 and sell it today you would earn a total of 0.19 from holding Ligand Pharmaceuticals General or generate 61.29% return on investment over 90 days. Ligand Pharmaceuticals General is currently producing 30.7048% returns and takes up 109.063% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Ligand, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Ligand Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ligand Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Ligand Pharmaceuticals General, and traders can use it to determine the average amount a Ligand Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2815
| Best Portfolio | Best Equity | LGNYZ | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 109.06 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.07 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.28 actual daily | 21 79% of assets perform better |
Based on monthly moving average Ligand Pharmaceuticals is performing at about 21% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ligand Pharmaceuticals by adding it to a well-diversified portfolio.
Ligand Pharmaceuticals Fundamentals Growth
Ligand Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Ligand Pharmaceuticals, and Ligand Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ligand Pink Sheet performance.
| Revenue | 277.13 M | |||
| EBITDA | 98.42 M | |||
| Cash Flow From Operations | 78.8 M | |||
| Total Asset | 1.3 B | |||
About Ligand Pharmaceuticals Performance
To evaluate Ligand Pharmaceuticals Pink Sheet as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Ligand Pharmaceuticals generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Ligand Pink Sheet's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Ligand Pharmaceuticals market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Ligand's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Things to note about Ligand Pharmaceuticals performance evaluation
Checking the ongoing alerts about Ligand Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Ligand Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ligand Pharmaceuticals is not yet fully synchronised with the market data | |
| Ligand Pharmaceuticals is way too risky over 90 days horizon | |
| Ligand Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Ligand Pharmaceuticals appears to be risky and price may revert if volatility continues |
- Analyzing Ligand Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ligand Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Ligand Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ligand Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ligand Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ligand Pharmaceuticals' pink sheet. These opinions can provide insight into Ligand Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Ligand Pink Sheet analysis
When running Ligand Pharmaceuticals' price analysis, check to measure Ligand Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ligand Pharmaceuticals is operating at the current time. Most of Ligand Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ligand Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ligand Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ligand Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |